Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.255 USD | +0.99% | +1.92% | -87.97% |
Mar. 28 | Transcript : ENDRA Life Sciences Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
Mar. 28 | ENDRA Life Sciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.97% | 2.79M | |
+2.17% | 42.75B | |
+47.70% | 41.61B | |
+12.45% | 41.34B | |
-12.36% | 26.59B | |
+7.72% | 25.49B | |
-22.96% | 18.12B | |
+30.55% | 12.24B | |
-2.00% | 11.76B | |
+8.09% | 11B |
- Stock Market
- Equities
- NDRA Stock
- News ENDRA Life Sciences Inc.
- ENDRA Life Sciences Gets European Patent for Body Fat Concentration Measurement System; Shares Gain